American Century Companies Inc Monte Rosa Therapeutics, Inc. Transaction History
American Century Companies Inc
- $167 Billion
- Q3 2024
A detailed history of American Century Companies Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 60,365 shares of GLUE stock, worth $549,925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,365
Previous 49,410
22.17%
Holding current value
$549,925
Previous $184,000
73.37%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GLUE
# of Institutions
83Shares Held
43.9MCall Options Held
141KPut Options Held
31.2K-
Nea Management Company, LLC Timonium, MD7.69MShares$70.1 Million3.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$60.1 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.79MShares$52.7 Million0.46% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$44.8 Million0.28% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.66MShares$24.2 Million0.55% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $426M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...